Navigation Links
Onconase has Potential as Chemopreventive Agent in Mesothelioma,,Reports World-Renowned Mesothelioma Researcher at AACR Annual,Meeting

pressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, uncertainties involved in transitioning from concept to product, uncertainties involving the ability of the company to finance research and development activities, potential challenges to or violations of patents, uncertainties regarding the outcome of clinical trials, the company's ability to secure necessary approvals from regulatory agencies, dependence upon third-party vendors, and other risks discussed in the company's periodic filings with the Securities and Exchange Commission. By making these forward-looking statements, the company undertakes no obligation to update these statements for revisions or changes after the date of this release.

    Media Contact:                      Investor Contact:

    David Schull or Wendy Lau           Andreas Marathovouniotis

    Noonan Russo                        Noonan Russo

    212-845-4271                        212-845-4253

               

    

david.schull@eurorscg.com andreas.marathis@eurorscg.com wendy.lau1@eurorscg.com

CONTACT: David Schull or Wendy Lau, +1-212-845-4271, or, or , or AndreasMarathovouniotis, +1-212-845-4253, or , all ofNoonan Russo david.schull@eurorscg.com wendy.lau1@eurorscg.com andreas.marathis@eurorscg.com

Web site: http://www.alfacell.com/http://www.noonanr
'"/>





Page: 1 2 3 4

Related medicine technology :

1. Preclinical Data Show Alfacells Onconase Inhibits Tumor Growth of Non-Small Cell Lung Cancer, Breast Cancer Cells
2. Researchers Identify Intracellular Pathway of Alfacells Onconase
3. In vivo Study Results Demonstrating Potential of Alfacells Onconase for Treatment of Non-Small Cell Lung Cancer Published in Anticancer Research
4. Studies Show Mild Hyperthermia Enhances Antitumor Effects of Alfacells Onconase
5. Alfacells Onconase Highlighted in Latest Edition of Handbook of Therapeutic Antibodies
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. New Information on the Potential of Plasmin Shared at ISTH Congress
8. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
9. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
10. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
11. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme

Post Your Comments:
(Date:11/20/2009)... Smith & Nephew ( SN...nounce the signing of a technology development con... that may lead to the creation of a fracture fixat... of the limbs of soldiers who sustain battlefield ...search Projects Agency (DARPA), the central resear...
(Date:11/19/2009)... Warner Chilcott plc (Nasdaq: WCR...announced secondary offering of 20,000,000 of its ... per share. The selling shareholders include fund...ant Banking, J.P. Morgan Partners (advised by CCMP...n other institutional investors and members of the...
(Date:11/19/2009)...RNewswire/ -- In response to an ever-increasing nu...edicines, Operation Pangea II, involving 24 countr...lth Organization,s International Medical Products ...t the dangers of buying medicines online. ,, Th... of arrests and the seizure of thousands of potent...
Breaking Medicine Technology:Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2Victhom announces completion of joint venture agreement with Otto Bock for Neurobionix activities 12700 1Victhom announces completion of joint venture agreement with Otto Bock for Neurobionix activities 12700 2Victhom announces completion of joint venture agreement with Otto Bock for Neurobionix activities 12700 3Victhom announces completion of joint venture agreement with Otto Bock for Neurobionix activities 12700 4Teens Young Adults Need More Calcium 49403 1Teens Young Adults Need More Calcium 49403 2Size did matter 8906 1
... Pivotal Study Highlighted at Recent Arizona Alzhe...in Phoenix -, PHOENIX and SUN CITY, Ariz., June 9...arch Institute today announced that they are,activ...tigational drug,Dimebon(TM) for the treatment of A...fety and efficacy of Dimebon in patients with Alzh...
...sive Report of Bile Acid Aberration in Type 2 Diab...ther Study, EMERYVILLE, Calif. and PARSIPPANY, N...., and Daiichi Sankyo, Inc., announced that researc... metabolism in people with type 2,diabetes which m..., It has long been known that bile acids help the...
Other Medicine Technology:Banner Alzheimer's Institute and Sun Health Research Institute Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimer's Disease 2Banner Alzheimer's Institute and Sun Health Research Institute Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimer's Disease 3New Discovery of Key Difference in Bile Acid Metabolism in Patients with Type 2 Diabetes May Suggest Underlying Disorder 2New Discovery of Key Difference in Bile Acid Metabolism in Patients with Type 2 Diabetes May Suggest Underlying Disorder 3New Discovery of Key Difference in Bile Acid Metabolism in Patients with Type 2 Diabetes May Suggest Underlying Disorder 4New Discovery of Key Difference in Bile Acid Metabolism in Patients with Type 2 Diabetes May Suggest Underlying Disorder 5New Discovery of Key Difference in Bile Acid Metabolism in Patients with Type 2 Diabetes May Suggest Underlying Disorder 6New Discovery of Key Difference in Bile Acid Metabolism in Patients with Type 2 Diabetes May Suggest Underlying Disorder 7
(Date:11/21/2009)...Group ask whether there is a secret to ,alcohol re... London, UK (PRWEB) November 21, 2009...ree of the adult UK population drinking enough alc...d liver disease*, it is hardly a surprise that man...ammes and residential centres for help. However, f...
(Date:11/20/2009)... Following a recall by Unilever The...sale Shedd,s Country Crock ® Side Dishes DELU... ® Side Dishes DELUXE Four Cheese Pasta due t...wing code dates and UPCs are affected: ,, Shed...r Broccoli Rice 21 oz, UPC 027400218316, Best By N...
(Date:11/20/2009)...ovember 20 Cardio Vascul...LMEDICAL.COM , a leading,developer of advanced car...at,the company,s Board of Directors has decided to...d the Far East for its proprietary next-generation...sty (PCTA) procedures. , Cardio Vascular ...
(Date:11/20/2009)...rmaldehyde used for embalming in the funeral indus...h from myeloid leukemia, according to a new study ...e National Cancer Institute . , Previous studies...tic malignancies and brain cancer in anatomists, p...whom may have worked with formaldehyde. , For ...
(Date:11/20/2009)...ing 90-day supply, study finds , , FRIDA...h supply of prescription drugs is up to one-third ...to a new study. , U.S. researchers analyzed 26,...0 and 2005, and found that patients who bought a t...ved an average 29 percent in out-of-pocket costs. ...
Breaking Medicine News(10 mins):Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 4Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2Health News:Funeral industry workers exposed to formaldehyde face higher risk of leukemia 2Health News:Three-Month Supply Lowers Drug Costs 2
...es brought by AIDS to China in the coming five yea...5 billion), said a renowned AIDS expert here Wedne...y of Sciences (CAS), Zeng Yi, chief scientist with... China are estimated to reach 285.57 billion yuan ...
...o group of hospitals is all set to open its 100-be...his year//. A report in the Times of Oman new... director V.T. Saileswaran as saying that the hosp...and polyclinics in the Gulf nation. Said AMC...
...sumption of narcotics substances is potentially le...sing supply of spurious drugs //that is leading to... especially when consumed with alcohol, according ...case of cocaine and heroin, paracetamol and diazep...
... agencies in Tamil Nadu are demanding monitoring s...study found air samples //from the state among the...d the Tamil Nadu Pollution Control Board to apply ...ustrialised areas. The demand came after tw...
...the medical parlance it has become mandatory for t... feed them exclusively on breast milk //alone for ...ut that notion has now been strongly challenged by...istant professor in the pulmonary, critical care, ...
...etts observatory unveiled light signals transmitte...//. It will cover 100,000 times the amount of ... developers of the new telescope. Space expl...als to communicate as radio transmissions. H...
Other Medicine News:Health News:Spurious Drugs is a Leading Cause of Casualties Among Drug Users 2Health News:Air Pollution in Tamil Nadu is a Cause of Concern for Environmentalists 2Health News:Earlier Introduction of Solid Foods in Infants Could Prevent Wheat Allergy 2
LDL-C Select FS
Direct LDL Cholesterol Reagent
Uric Acid (Uricase)
Uric Acid (TPTZ)
Medicine Products: